NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Yourgene Health Plc (LSE: YGEN)

 
YGEN Technical Analysis
1
As on 11th Jul 2023 YGEN STOCK Price closed @ 0.49 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

YGENSTOCK Price

Open 0.49 Change Price %
High 0.50 1 Day N/A N/A
Low 0.49 1 Week 0.00 0.00
Close 0.49 1 Month 0.00 0.00
Volume 135491509 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
LSE UK Most Active Stocks
DKE 0.15 0.00%
NNN 0.09 %
SYME 0.10 %
DMTR 0.03 0.00%
PREM 0.53 %
MCLS 1.68 46.09%
YGEN 0.49 %
CLON 0.11 %
VOD 71.04 %
BOIL 0.10 %
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
VENC 139.60 65.21%
0UTC 0.41 51.85%
MCLS 1.68 46.09%
0ZU5 0.07 40.00%
0RNL 0.87 31.82%
0J03 3.10 30.80%
0I5R 0.13 30.00%
CIP 50.00 25.00%
CIP 50.00 25.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
YGEN
Daily Charts
YGEN
Intraday Charts
Whats New @
Bazaartrend
YGEN
Free Analysis
 
YGEN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
YGEN Forecast December 2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
YGEN Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
YGEN Forecast2023
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
YGEN Other Details
Segment EQ
Market Capital 95292880.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
YGEN Address
YGEN
 
YGEN Latest News
 
Your Comments and Response on Yourgene Health Plc
 
YGEN Business Profile
Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome and other genetic disorders in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom. Address: Citylabs 1.0, Manchester, United Kingdom, M13 9NQ
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service